3United States Pharmacopoeia Committee. United States Pharmacopoeia[S].32th. ed. Washington DC:The United States Pharmacopeial Convention Inc,2009:3843-3848.
5Food and Drug Administration. Guidance for industry:Dissolution testing of immediate release solid oral dosadgeform [EB/OL]. http://www.fda.gov/cder/guidance.htm.
